Announcement

Collapse
No announcement yet.

Stem Cells Therapy for Spinal Cord Injury: An Overview of Clinical Trials

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

    Stem Cells Therapy for Spinal Cord Injury: An Overview of Clinical Trials

    Int J Mol Sci. 2020 Jan; 21(2): 659.


    Serena Silvestro,1 Placido Bramanti,1 Oriana Trubiani,2 and Emanuela Mazzon1,*
    Author information Article notes Copyright and License information Disclaimer
    Abstract


    Spinal cord injury (SCI) is a traumatic lesion that causes disability with temporary or permanent sensory and/or motor deficits. The pharmacological approach still in use for the treatment of SCI involves the employment of corticosteroid drugs. However, SCI remains a very complex disorder that needs future studies to find effective pharmacological treatments. SCI actives a strong inflammatory response that induces a loss of neurons followed by a cascade of events that lead to further spinal cord damage. Many experimental studies demonstrate the therapeutic effect of stem cells in SCI due to their capacity to differentiate into neuronal cells and by releasing neurotrophic factors. Therefore, they appear to be a valid strategy to use in the field of regenerative medicine. The purpose of this paper is to provide an overview of clinical trials, recorded in clinical trial.gov during 2005–2019, aimed to evaluate the use of stem cell-based therapy in SCI. The results available thus far show the safety and efficacy of stem cell therapy in patients with SCI. However, future trials are needed to investigate the safety and efficacy of stem cell transplantation.


    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013533/
    “As the cast of villains in SCI is vast and collaborative, so too must be the chorus of hero's that rise to meet them” Ramer et al 2005
Working...
X